The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation

Abstract Background The benefit-risk profile of direct oral anticoagulants (DOAC) therapy in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) has not been well established yet. This study aimed to evaluate the efficacy and safety of DOAC compared with vitamin K antagonist...

Full description

Bibliographic Details
Main Authors: Si-qi Lyu, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing-hui Shao, Yan-min Yang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Thrombosis Journal
Subjects:
Direct oral anticoagulants
Vitamin K antagonists
Hypertrophic cardiomyopathy
Atrial fibrillation
Meta-analysis
Online Access:https://doi.org/10.1186/s12959-023-00562-8

Internet

https://doi.org/10.1186/s12959-023-00562-8

Similar Items